Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Scaffold Free 3D Cell Culture Market size was over USD 75.77 billion in 2024 and is poised to exceed USD 301.2 billion by 2037, growing at over 11.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of scaffold free 3D cell culture is evaluated at USD 82.98 billion.
The growth of the market can be attributed to the growing emphasis on developing alternatives to animal testing, and rising focus on personalized medicine around the world. In the United States alone, a total of 286 personalized medicines were available in 2020. In addition, the investments in these medicines in the country grew by 53% in the years 2011-2015. Along with these, increasing incidences of chronic diseases, and upsurge in funding for cell-based research globally are also expected to drive market growth in the forthcoming years. In 2019, there were more than 15 million deaths from all types of cardiovascular diseases across the globe. Also, cancer and respiratory diseases caused about 9 million and 4 million deaths that same year. Furthermore, escalating investments in the healthcare sector, and growth in the number of cases of infectious diseases, such as H1N1 and influenza, are projected to offer ample growth opportunities to the market in the near future.
Scaffold Free 3D Cell Culture Sector: Growth Drivers and Challenges
Growth Drivers
- Growing Emphasis on Developing Alternatives to Animal Testing
- Rising Focus on Personalized Medicine Around the World
Challenges
- High Cost of Cell Culture Research
Scaffold Free 3D Cell Culture Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
11.2% |
|
Base Year Market Size (2024) |
USD 75.77 billion |
|
Forecast Year Market Size (2037) |
USD 301.2 billion |
|
Regional Scope |
|
Scaffold Free 3D Cell Culture Segmentation
The market is segmented by end user industry into pharmaceutical, biotech, and cosmetics, out of which, the pharmaceutical segment is anticipated to hold the largest share in the global scaffold free 3D cell culture market. This can be accounted to the rising preference for alternative testing models over animal techniques in this industry, and increasing investments for R&D activities in pharmaceutical companies. Additionally, on the basis of type, the stem cell culture segment is assessed to occupy the largest share during the forecast period, which can be credited to the growing occurrence of cancer across the globe. Apart from this, allocation of high investments for cancer research by governments worldwide is also predicted to boost the growth of the market segment in the years to come.
Our in-depth analysis of the global market includes the following segments:
|
By Type |
|
|
By Application |
|
|
By End User Industry |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportScaffold Free 3D Cell Culture Industry - Regional Synopsis
Regionally, the global scaffold free 3D cell culture market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa region. The market in Europe industry is set to hold largest revenue share by 2037, backed by rapidly growing pharmaceutical & biotechnology industry, and rising commercialization of microfluidics-based 3D cell culture in the region. In addition, strong presence of market players is also expected to fuel the market growth in the region in the region in the future. Moreover, the market in North America is projected to acquire the largest share by the end of 2031 owing to the surging prevalence of cancer, and well-established healthcare infrastructure in the region. According to the Centers for Disease Control and Prevention (CDC), in 2018, 1,708,921 new cancer cases were reported and 599,265 people died of the same in the United States. For every 100,000 people, 436 new cancer cases were reported and 149 people died of cancer.
Companies Dominating the Scaffold Free 3D Cell Culture Landscape
- Kuraray Co., Ltd
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Thermo Fisher Scientific, Inc.
- Merck & Co., Inc.
- General Electric Company
- Danaher Corporation
- Becton, Dickinson and Company
- QGel SA
- Hµrel Corporation
- Hamilton Company
- Lonza AG
In the News
-
October 2021- Merck launched Millicell DCI Digital Cell Imager, which is an instrument that helps in improving cell culture lab productivity by assessing parameters such as confluency, morphology, and cell growth trends.
-
March 2021- Thermo Fisher Scientific unveiled new human plasma-like cell culture medium that is able to mimic the metabolic profile of human plasma.
Author Credits: Radhika Pawar
- Report ID: 3934
- Published Date: Dec 26, 2024
- Report Format: PDF, PPT
